00842nas a2200301   4500000000100000008004100001100001300042700001400055700001600069700001500085700001500100700001600115700001200131700001300143700001300156700001600169700001500185700001600200700001600216700001200232700002800244700001500272245016600287250001800453300001200471490000800483020004900491       2014                            d1 aRyden L.1 aTardif J.1 aNicholls S.1 aGrobbee D.1 aLincoff A.1 aMalmberg K.1 aBuse J.1 aHenry R.1 aWedel H.1 aWeichert A.1 aCannata R.1 aSchwartz G.1 aSvensson A.1 aVolz D.1 aAleCardio Investigators1 aNeal Bruce00aEffect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial  a30 March 2014  a1515-250 v311  a1538-3598 (Electronic) - 0098-7484 (Linking)